LDO PLUS
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 21 Feb 2023)
What this means for you
Registered since 16 Aug 2016. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86398159
- Registration number
- 5023129
- Mark type
- Stylized text
- Filed
- 17 Sept 2014
- Published for opposition
- 10 Feb 2015
- Registered
- 16 Aug 2016
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for topical gels and ointments for transdermal delivery of analgesics, anti-inflammatory agents, antineoplastic agents, muscle relaxants, anaesthetic agents, peptides, proteins, growth factors, hormones, substance P antagonists, antifungal compounds, antiviral compounds, antibacterial compounds, antiobesity drugs, homeopathic agents, antianginal compounds, hair growth stimulators or retardants, nutrients, and antimetabolites
Owner
- Gensco Laboratories, LLC, Doral, FL, US
- Gensco Laboratories, LLC, Doral, FL, US
- Gensco Laboratories, LLC, Doral, FL, US
Prosecution history
- 16 Aug 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 21 Feb 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 21 Feb 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 21 Feb 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 04 Aug 2022 — TEAS SECTION 8 & 15 RECEIVED
- 16 Aug 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 16 Aug 2016 — REGISTERED-PRINCIPAL REGISTER
- 13 Jul 2016 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 12 Jul 2016 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 22 Jun 2016 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 22 Jun 2016 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 16 Jun 2016 — ASSIGNED TO LIE
- 09 Jun 2016 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 09 May 2016 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 09 May 2016 — NON-FINAL ACTION E-MAILED